Tami StoweMar 3Pharma Reimbursement HUBs: To Audit, or not to Audit?While the norm is to view an audit as a stressful, time-consuming experience, audits can paint a picture not visible to the naked eye and ar
Team ArchbowJul 23, 2019What to know before you migrate a Patient Service ProgramArchbow's experience with program migrations has taught us what to anticipate, how to formulate realistic expectations, and where to fin
Kevin CastMay 29, 2019Why “Demand Chain” is the new “Supply Chain” in Cell and Gene TherapyFor cell and gene therapies, there's a marketplace shift happening from "Supply Chain" to "Demand Chain." Keep up wi
Justine HughesMar 12, 2019Build a Better PatientIs your pharma company looking for new ways to drive better outcomes? Try building better patients.
Sheryl HeinleJul 16, 2018Quality: pharma’s forgotten differentiatorPoor quality within a HUB can lead to delays in patient treatment, loss of prescriber confidence, and users seeking competitive therapeutic
Team ArchbowJun 12, 2018How to know if your program needs to be optimizedWhen asked the big question, "How do I know if my pharma patient access program needs to be optimized?" we share this list.
Team ArchbowMay 21, 20185 things I wish I knew before my first pharma technology projectTami Stowe has been operationalizing pharma access programs for more than 18 years. Because her career has evolved alongside our industry
Team ArchbowMay 7, 2018The three hottest topics in specialty todayIf gene therapies, digitalization, and copay accumulators are top of mind concerns, you're not alone. Read our takeaways on these pressi
DeWayne ManningApr 2, 2018Pharma Digitalization 101 | PharmaDCXPharmaDCX, or Pharma Digital Customer Experience, is the integration of digital technology into all areas of business, resulting in fundamen
Katie RappMar 12, 2018Best practices for pharma internal project communicationsWhen a promising project fails to meet expectations, poor communication is often a contributing cause. We advise our pharma clients to incor
Sheryl HeinleJan 30, 2018Blue Ocean thinking creates REMS opportunityCase study: pharma effectively using Blue Ocean thinking to create opportunity out of mature REMS program.
Team ArchbowJan 12, 201810 pharma and biotech trends to watch in 2018Archbow Consulting worked with Pharmaceutical Executive to highlight ten pharma and biotech trends worth watching in 2018. Everything from t
Sheryl HeinleDec 8, 2017Differentiate your brand with a Blue Ocean approachThrough Blue Ocean thinking, successful pharma and biotech brands are shifting focus from the competition to the customer.
Douglas BockOct 31, 2017How to avoid a FrankenLaunchFrankenLaunches happen when multiple vendors and consultants advise on different, yet interconnected elements of a brand’s launch.
DeWayne ManningOct 20, 20177 questions to select the right e-servicesTechnology will undoubtedly have a positive impact on the specialty pharmaceutical business. And, within the right context, e-services can
Kevin CastSep 10, 20177 ways to optimize your outsourcingGood outsourcing can make or break brand success. Are you preparing for a product launch that could benefit from an outsourcing assessment?
